Generation of plasmacytomas with the chromosomal translocation t(12;15) in interleukin 6 transgenic mice.
about
Interleukin-6, CD45 and the src-kinases in myeloma cell proliferationCD19 expression and growth inhibition of tumours in human multiple myelomaTransplantable myeloproliferative disease induced in mice by an interleukin 6 retrovirus.TPL2 kinase regulates the inflammatory milieu of the myeloma nicheStat3 activation is required for cellular transformation by v-src.IL-6 transgenic mouse model for extraosseous plasmacytoma.Proliferation of immature myeloma cells by interleukin-6 is associated with CD45 expression in human multiple myeloma.Interleukin-6 (IL-6) and IL-17 synergistically promote viral persistence by inhibiting cellular apoptosis and cytotoxic T cell functionMolecular cloning of the complementary DNA and gene that encode mouse brain natriuretic peptide and generation of transgenic mice that overexpress the brain natriuretic peptide geneContinuous activation of gp130, a signal-transducing receptor component for interleukin 6-related cytokines, causes myocardial hypertrophy in mice.Impact of interleukin-6 in hematological malignancies.A new model of LMP1-MYC interaction in B cell lymphoma.The therapeutic potential of interleukin-6 hyperagonists and antagonists.A human GM-CSF receptor expressed in transgenic mice stimulates proliferation and differentiation of hemopoietic progenitors to all lineages in response to human GM-CSF.RKIP phosphorylation and STAT3 activation is inhibited by oxaliplatin and camptothecin and are associated with poor prognosis in stage II colon cancer patients.Genetic reporter system for oncogenic Igh-Myc translocations in mice.Destabilization of interleukin-6 mRNA requires a putative RNA stem-loop structure, an AU-rich element, and the RNA-binding protein AUF1.Therapeutic effects of thalidomide in myeloma are associated with the expression of fibroblast growth factor receptor 3Survival and proliferation factors of normal and malignant plasma cells.CDKN1A and FANCD2 are potential oncotargets in Burkitt lymphoma and multiple myelomaCutting edge: Calcium/Calmodulin-dependent protein kinase type IV is essential for mesangial cell proliferation and lupus nephritis.SOCS3 deletion in B cells alters cytokine responses and germinal center output.Consistent loss of functional transforming growth factor beta receptor expression in murine plasmacytomasDefective development of pristane-oil-induced plasmacytomas in interleukin-6-deficient BALB/c mice.Transgenic mouse model of AA amyloidosis.Bone marrow neutrophilia and suppressed bone turnover in human interleukin-6 transgenic mice. A cellular relationship among hematopoietic cells, osteoblasts, and osteoclasts mediated by stromal cells in bone marrowmiR-744 enhances type I interferon signaling pathway by targeting PTP1B in primary human renal mesangial cellsHHV-8-encoded viral IL-6 collaborates with mouse IL-6 in the development of multicentric Castleman disease in miceTransgenic mice in the study of cytokine functionAID-deficient Bcl-xL transgenic mice develop delayed atypical plasma cell tumors with unusual Ig/Myc chromosomal rearrangements.A role for AID in chromosome translocations between c-myc and the IgH variable region.Progenitor cell hyperplasia with rare development of myeloid leukemia in interleukin 11 bone marrow chimeras.The function of the soluble interleukin 6 (IL-6) receptor in vivo: sensitization of human soluble IL-6 receptor transgenic mice towards IL-6 and prolongation of the plasma half-life of IL-6.Interleukin-6: discovery of a pleiotropic cytokine.A major role for Mcl-1 antiapoptotic protein in the IL-6-induced survival of human myeloma cells.Malignancy rates in patients with rheumatoid arthritis treated with tocilizumab.Interleukin-6 expands homeostatic space for peripheral T cellsThe role of interleukin-6 in the expression of PD-1 and PDL-1 on central nervous system cells following infection with Theiler's murine encephalomyelitis virus.Quantitative tomography of early-onset spontaneous AA amyloidosis in interleukin 6 transgenic miceInterleukin 6 receptor antibody inhibits muscle atrophy and modulates proteolytic systems in interleukin 6 transgenic mice.
P2860
Q28210841-FF2CBF88-CEBB-4CAF-ABC8-B82E8F5D49D8Q28217091-C96A714B-AFBE-4350-BC4C-71ACAEF16464Q33354120-8AC1A9CB-468C-4258-A9DE-7D9C5E4BEBF4Q33714724-E48BE696-1BB0-403C-B229-3422FC1D5916Q33786469-8A2FFE05-61BE-4FE1-A7AE-E7E3FEA1B062Q34009997-D0312E46-BD41-438D-8BB7-C094D9E4C1E3Q34024246-9438EF0F-15A4-4547-875E-D86FF61A9891Q34057935-091B73E5-707C-4430-BF56-D5847B273C9AQ34142903-4967BE0B-5129-44FE-9255-737FFCD2A435Q34270015-62F2258A-2D84-46ED-9000-4D306DA38F08Q34387624-2A4DBF9D-C81C-420C-91D0-D555BADD0881Q34395376-DD1B2D80-259A-45F2-9E09-B8FC7E959008Q34430168-8B2F305F-D09A-4889-983B-ED9BEEA66BFEQ34448342-2CE1D819-4224-4FB1-91E6-EEEC71034D38Q35010521-186A51BF-30B6-4A1C-A356-C59BD72C0D88Q35026963-222C8E7C-2B45-4D13-A220-31CEDA54B884Q35131515-361B1711-14D1-4FD6-8295-F1028EADE629Q35166712-A1B0E41D-E044-4DC1-9FB6-57BBC61DC0F0Q35211028-57D21D7E-D144-4FC5-B479-F8C132F4F206Q35247381-58CE4FEB-12C2-40D0-85C9-49191E3D9AB4Q35566402-FA654220-736B-4C90-A48A-29C6720FA405Q35663095-902BAB10-6CE6-454D-B761-F667DEA7F607Q35671557-EB517CEE-CEF4-42F1-BC88-613E2431B10DQ35763419-B4FB93D3-2334-467C-80E4-82E3F4ABA268Q35786782-D37BDA37-B31F-46FC-9463-EAF4F134B7EAQ35796423-86A0984B-314E-49C6-99EA-1F3C889DD50AQ35936143-E965E7DB-A188-44CD-864B-8BF26C8671F0Q36018434-0744EB0A-56F7-4631-B79D-E7706C10E3EAQ36029215-32A192C6-28D1-4BE0-8177-CE6353054BFBQ36229165-95CB8E40-7167-41B8-888A-43F4247FE1C5Q36229681-FFEC1B95-07D5-46DD-9BFC-F924E262A6A4Q36362432-03FA3223-7B16-4EB0-A17F-C2AC7F4583E7Q36366332-413AF12E-E9D3-4E2E-8A1A-75864207E90DQ36561156-69E99891-E19C-4AF2-8EDC-E9B220F1F6B9Q36675950-BC75F254-07C5-4064-80D5-2E380281E213Q36919914-6C996F07-2AD8-486C-B716-201B2D087AB2Q37249975-F9CB11AE-5613-41C6-A67F-E21310BE4F08Q37252711-8AF4A63C-F5DE-4969-865D-43C444E25E92Q37261989-725FFAAB-854A-4A75-9497-5BE19A4CD40FQ37351404-B4CD006D-0757-4DA9-BD62-17024BD5C381
P2860
Generation of plasmacytomas with the chromosomal translocation t(12;15) in interleukin 6 transgenic mice.
description
1992 nî lūn-bûn
@nan
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
1992年论文
@zh
1992年论文
@zh-cn
name
Generation of plasmacytomas wi ...... interleukin 6 transgenic mice.
@ast
Generation of plasmacytomas wi ...... interleukin 6 transgenic mice.
@en
type
label
Generation of plasmacytomas wi ...... interleukin 6 transgenic mice.
@ast
Generation of plasmacytomas wi ...... interleukin 6 transgenic mice.
@en
prefLabel
Generation of plasmacytomas wi ...... interleukin 6 transgenic mice.
@ast
Generation of plasmacytomas wi ...... interleukin 6 transgenic mice.
@en
P2093
P2860
P356
P1476
Generation of plasmacytomas wi ...... interleukin 6 transgenic mice
@en
P2093
K Yamamura
S Suematsu
T Kishimoto
T Matsusaka
P2860
P304
P356
10.1073/PNAS.89.1.232
P407
P577
1992-01-01T00:00:00Z